title: [Prognostic factors in adenocarcinoma of the endometrium].
abstract: We report the results of the combined use of surgery and radiation therapy in the treatment of endometrial carcinoma. From January 1974 to December 1989, 89 cases were treated by means of abdominal hysterectomy followed by external radiation therapy. Actuarial survival at 5 years is 100% for stage I, 75% for stage II, and 42.86% for stage III; stage IV patients could not be evaluated. Prognostic factors were statistically significant. In stages II and III survival rates were directly related to histological grading (G1: 90.91%; G2: 81.82%; G3: 25%) and to myometrial infiltration (M1: 85.71%; M2: 81.82%; M3: 70%). Generally, survival was related to age, and prognosis was better in younger patients (under 55) and depended on lymph nodal involvement (N-: 88.24%, versus N+: 25%). Vaginal and pelvic recurrences were 8 (10.1%), and deaths were 13. The identification of high-risk patients will make it possible to select an even more adequate treatment.
authors.affiliation: Divisione di Radioterapia, Ospedale Mauriziano Umberto, Torino.
authors.forename: C
authors.initials: C
authors.lastname: Giordana
authors.forename: G
authors.initials: G
authors.lastname: Malinverni
authors.forename: C
authors.initials: C
authors.lastname: Rosmino
authors.forename: F
authors.initials: F
authors.lastname: Del Tetto
authors.forename: N
authors.initials: N
authors.lastname: Ravarino
authors.forename: S
authors.initials: S
authors.lastname: Sala
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality* / Q000473:pathology / Q000532:radiotherapy / Q000556:secondary; D000368:Aged; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D015996:Survival Rate; D014594:Uterine Neoplasms / Q000401:mortality* / Q000473:pathology / Q000532:radiotherapy